Terms: = Uterine cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626
95 results:
1. The Mediator Complex Subunit 12 (MED-12) Gene and uterine Fibroids: a Systematic Review.
Amendola ILS; Spann M; Segars J; Singh B
Reprod Sci; 2024 Feb; 31(2):291-308. PubMed ID: 37516697
[TBL] [Abstract] [Full Text] [Related]
2. [Clinicopathological analysis of primary gastric (gastrointestinal)-type mucoglandular lesion of endometrium].
Zhang H; Xiang W; Ji ST; Xiao YP; Chen XC; Li J; Ning Y; Gu WY
Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):586-591. PubMed ID: 37263923
[No Abstract] [Full Text] [Related]
3. Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, cdx2, p53, and MSI status.
da Silva JL; de Albuquerque LZ; Rodrigues FR; Bastos NC; Small IA; Barroso EBC; Cordero FL; Fernandes DS; Paulino E; de Melo AC
PLoS One; 2023; 18(5):e0285447. PubMed ID: 37200263
[TBL] [Abstract] [Full Text] [Related]
4. A Clinical Prediction Model of Overall Survival for Patients with Cervical cancer Aged 25-69 Years.
Fan W; Lu Q; Liu G
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984601
[No Abstract] [Full Text] [Related]
5. Primary HPV-Associated Enteric-Type Adenocarcinoma of Vagina: A Case Report.
Felicelli C; Strickland A; Wei JJ
Int J Surg Pathol; 2023 Oct; 31(7):1393-1397. PubMed ID: 36694422
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
7. Postchemotherapy Endometrioid to Gastrointestinal Histotype Shift in Recurrent Endometrial Carcinoma.
Arciuolo D; Travaglino A; Santoro A; Pedone Anchora L; Inzani F; Angelico G; D'Alessandris N; Scaglione G; Valente M; Raffone A; Fanfani F; Zannoni GF
Int J Gynecol Pathol; 2022 Nov; 41(6):583-587. PubMed ID: 36302189
[TBL] [Abstract] [Full Text] [Related]
8. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
9. Yolk Sac Tumor Originating From Cervical Adenocarcinoma: A Case Predominated by Enteroblastic Differentiation.
Liu XL; Ding L; Lu X; Hu YJ; Zhou XL; Lin DL
Int J Gynecol Pathol; 2023 Mar; 42(2):212-216. PubMed ID: 35639370
[TBL] [Abstract] [Full Text] [Related]
10. PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS; Won S; Kim JH; Lee N; Kim M; Kim MK; Kim ML; Jung YW; Kim JY; Seong SJ; Shin E
J Ovarian Res; 2022 Apr; 15(1):41. PubMed ID: 35387670
[TBL] [Abstract] [Full Text] [Related]
11. Intestinal-type mucinous ovarian carcinoma arising from a seromucinous precursor lesion.
Santoro A; D'Alessandris N; Travaglino A; Arciuolo D; Inzani F; Angelico G; Scaglione G; Valente M; Raffone A; Zannoni GF
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(4):1263-1267. PubMed ID: 35253183
[TBL] [Abstract] [Full Text] [Related]
12. Unusual Ovarian Tumors With Endometrioid Proliferations Co-Expressing Estrogen Receptor and CDX-2 Arising in Cystadenofibromatous Background: Report of 3 Cases.
McMullen-Tabry ER; Sciallis AP; Udager AM; Skala SL
Int J Gynecol Pathol; 2023 Jan; 42(1):93-100. PubMed ID: 35149615
[TBL] [Abstract] [Full Text] [Related]
13. SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix.
Inzani F; Angelico G; Santoro A; Travaglino A; Insabato L; Raffone A; Arciuolo D; Scaglione G; D'Alessandris N; Valente M; Carlino A; Rindi G; Zannoni GF
Virchows Arch; 2022 Apr; 480(4):873-877. PubMed ID: 35091815
[TBL] [Abstract] [Full Text] [Related]
14. Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype: Implications for Lynch Syndrome Screening.
Rodriguez M; Kang EY; Farrington K; Cook LS; Le ND; Karnezis AN; Lee CH; Nelson GS; Terzic T; Lee S; Köbel M
Am J Surg Pathol; 2021 Nov; 45(11):1452-1463. PubMed ID: 34534137
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical cancer: Results from the EMBRACE-I Study.
Kirchheiner K; Smet S; Jürgenliemk-Schulz IM; Haie-Meder C; Chargari C; Lindegaard JC; Fokdal LU; Spampinato S; Schmid MP; Sturdza A; Mahantshetty U; Segedin B; Bruheim K; Rai B; Cooper R; Van der Steen-Banasik E; Wiebe E; Sundset M; van Limbergen E; Villafranca E; Westerveld H; Tan LT; Pötter R; Tanderup K; Nout RA;
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):400-413. PubMed ID: 34478833
[TBL] [Abstract] [Full Text] [Related]
16. Carcinosarcoma of the stomach with alpha-fetoprotein-producing hepatoid adenocarcinoma: an unexpected combination of two rare subtypes of gastric cancer in one tumor.
Li Z; Zhou Q; Lu J; Zhang H; Teng L
J Int Med Res; 2021 Aug; 49(8):3000605211037422. PubMed ID: 34407682
[TBL] [Abstract] [Full Text] [Related]
17. Metastatic uterine Carcinosarcoma to the Orbit.
Qureshi S; Patel NA; Patel N; Ghassibi MP; Tse DT; Dubovy SR
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):e198-e202. PubMed ID: 34284421
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic Pitfalls Related to Morular Metaplasia in Endometrioid Carcinoma: An Underestimated Issue.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Zullo F; Insabato L
Pathobiology; 2021; 88(3):261-266. PubMed ID: 33887731
[TBL] [Abstract] [Full Text] [Related]
19. FIGO Grade 3 Endometrioid Adenocarcinomas With Diffusely Aberrant β-Catenin Expression: An Aggressive Subset Resembling Cutaneous Pilomatrix Carcinomas.
Weisman P; Park KJ; Xu J
Int J Gynecol Pathol; 2022 Mar; 41(2):126-131. PubMed ID: 33811207
[TBL] [Abstract] [Full Text] [Related]
20. Does endometrial morular metaplasia represent odontogenic differentiation?
Travaglino A; Raffone A; Russo D; Guadagno E; Pignatiello S; Moretta P; Zullo F; Del Basso De Caro M; Insabato L; Mascolo M
Virchows Arch; 2021 Sep; 479(3):607-616. PubMed ID: 33666744
[TBL] [Abstract] [Full Text] [Related]
[Next]
